NYSEHealth CareHealth Care FacilitiesS&P MidCap 400
$283.33
-3.13 (-1.09%)
Close of Nov 06, 2026 · end-of-day data
Source: Tenet Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$21.07B
$20.61B
$18.31B
$18.48B
$17.64B
$19.48B
$19.17B
$20.56B
$20.68B
$21.31B
Operating income
$1.25B
$1.11B
$1.64B
$1.54B
$1.99B
$2.87B
$2.33B
$2.51B
$5.96B
$3.51B
Interest expense
$979.00M
$1.03B
$1.00B
$985.00M
$1.00B
$923.00M
$890.00M
$901.00M
$826.00M
$821.00M
Pre-tax income
$248.00M
-$101.00M
$629.00M
$320.00M
$671.00M
$1.89B
$1.34B
$1.62B
$5.25B
$2.80B
Income tax
$67.00M
$219.00M
$173.00M
$160.00M
-$97.00M
$411.00M
$344.00M
$306.00M
$1.18B
$433.00M
Net income
-$192.00M
-$704.00M
$104.00M
-$215.00M
$399.00M
$914.00M
$411.00M
$611.00M
$3.20B
$1.41B
EBITDA
$2.10B
$1.98B
$2.44B
$2.39B
$2.85B
$3.73B
$3.17B
$3.38B
$6.77B
$4.37B
EPS (basic)
$-1.93
$-7.00
$1.02
$-2.08
$3.80
$8.55
$3.84
$6.01
$33.02
$15.61
EPS (diluted)
$-1.93
$-7.00
$1.00
$-2.08
$3.75
$8.42
$3.79
$5.71
$32.70
$15.49
Diluted shares
99.32M
100.59M
103.88M
103.40M
106.26M
108.57M
110.52M
104.80M
97.88M
90.83M
Operating margin
5.9%
5.4%
8.9%
8.3%
11.3%
14.7%
12.2%
12.2%
28.8%
16.5%
Net margin
-0.9%
-3.4%
0.6%
-1.2%
2.3%
4.7%
2.1%
3.0%
15.5%
6.6%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$716.00M
$611.00M
$411.00M
$262.00M
$2.45B
$2.36B
$858.00M
$1.23B
$3.02B
$2.88B
Receivables
$2.90B
$2.62B
$2.60B
$2.74B
$2.69B
$2.77B
$2.94B
$2.91B
$2.54B
$2.56B
Inventory
$326.00M
$289.00M
$305.00M
$310.00M
$368.00M
$384.00M
$405.00M
$411.00M
$346.00M
$348.00M
Total current assets
$5.26B
$5.57B
$4.64B
$5.08B
$7.15B
$7.08B
$5.98B
$7.17B
$7.68B
$7.85B
Goodwill
$7.42B
$7.02B
$7.28B
$7.25B
$8.81B
$9.26B
$10.12B
$10.31B
$10.69B
$11.20B
Total assets
$24.70B
$23.39B
$22.43B
$23.36B
$27.11B
$27.58B
$27.16B
$28.31B
$28.94B
$29.68B
Total current liabilities
$4.03B
$4.33B
$3.86B
$4.21B
$4.85B
$5.11B
$4.48B
$4.76B
$4.31B
$4.46B
Short-term debt
$191.00M
$146.00M
$182.00M
$171.00M
$145.00M
$135.00M
$145.00M
$120.00M
$92.00M
$79.00M
Long-term debt
$15.06B
$14.79B
$14.64B
$14.58B
$15.57B
$15.51B
$14.93B
$14.88B
$13.08B
$13.09B
Total debt
$15.26B
$14.94B
$14.83B
$14.75B
$15.72B
$15.65B
$15.08B
$15.00B
$13.17B
$13.17B
Total liabilities
$21.23B
$20.98B
$20.30B
$21.42B
$24.22B
$23.32B
$22.55B
$22.80B
$20.39B
$20.70B
Shareholders' equity
$417.00M
-$147.00M
-$119.00M
-$417.00M
$28.00M
$1.03B
$1.14B
$1.61B
$4.17B
$4.22B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$558.00M
$1.20B
$1.05B
$1.23B
$3.41B
$1.57B
$1.08B
$2.37B
$2.05B
$3.54B
Capital expenditures
$875.00M
$707.00M
$617.00M
$670.00M
$540.00M
$658.00M
$762.00M
$751.00M
$931.00M
$1.01B
Free cash flow
-$317.00M
$493.00M
$432.00M
$563.00M
$2.87B
$910.00M
$321.00M
$1.62B
$1.12B
$2.53B
Investing cash flow
-$430.00M
$21.00M
-$115.00M
-$619.00M
-$1.61B
-$714.00M
-$808.00M
-$969.00M
$3.43B
-$1.27B
Financing cash flow
$232.00M
-$1.33B
-$1.13B
-$763.00M
$385.00M
-$936.00M
-$1.78B
-$1.03B
-$3.69B
-$2.40B
Share buybacks
$0
$0
—
—
$0
$0
$250.00M
$200.00M
$672.00M
$1.39B
Stock-based compensation
$68.00M
$59.00M
$46.00M
$42.00M
$44.00M
$56.00M
$56.00M
$66.00M
$67.00M
$104.00M
Depreciation & amortization
$850.00M
$870.00M
$802.00M
$850.00M
$857.00M
$855.00M
$841.00M
$870.00M
$818.00M
$863.00M
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$5.39B
$5.37B
$5.11B
$5.13B
$5.07B
$5.22B
$5.27B
$5.29B
$5.53B
$5.37B
$5.63B
$5.63B
Operating income
$735.00M
$3.29B
$761.00M
$1.09B
$821.00M
$943.00M
$823.00M
$889.00M
$853.00M
$1.30B
$1.50B
$1.75B
Interest expense
$227.00M
$218.00M
$203.00M
$202.00M
$203.00M
$204.00M
$206.00M
$206.00M
$205.00M
$205.00M
$204.00M
$203.00M
Pre-tax income
$519.00M
$3.08B
$587.00M
$922.00M
$655.00M
$765.00M
$642.00M
$712.00M
$681.00M
$1.13B
$1.34B
—
Income tax
$63.00M
$750.00M
$110.00M
$241.00M
$83.00M
$143.00M
$120.00M
$133.00M
$37.00M
$226.00M
$295.00M
$360.00M
Net income
$244.00M
$2.15B
$259.00M
$472.00M
$318.00M
$406.00M
$288.00M
$342.00M
$371.00M
$702.00M
$826.00M
$1.00B
EBITDA
$951.00M
$3.49B
$969.00M
$1.30B
$1.01B
$1.15B
$1.03B
$1.11B
$1.08B
$1.52B
$1.72B
$1.97B
EPS (basic)
$2.41
$21.60
$2.66
$4.93
$3.46
$4.31
$3.16
$3.89
$4.24
$8.09
$9.89
$12.48
EPS (diluted)
$2.30
$21.38
$2.64
$4.89
$3.43
$4.27
$3.14
$3.86
$4.21
$8.01
$9.84
$12.41
Diluted shares
-221.00K
100.60M
98.44M
96.65M
-637.00K
95.02M
91.79M
88.61M
-972.00K
87.60M
83.96M
80.60M
Operating margin
13.6%
61.2%
14.9%
21.2%
16.2%
18.1%
15.6%
16.8%
15.4%
24.1%
26.7%
31.1%
Net margin
4.5%
40.1%
5.1%
9.2%
6.3%
7.8%
5.5%
6.5%
6.7%
13.1%
14.7%
17.8%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$1.23B
$2.48B
$2.88B
$4.09B
$3.02B
$3.00B
$2.62B
$2.98B
$2.88B
$2.97B
$2.17B
$2.67B
Receivables
$2.91B
$3.15B
$2.82B
$2.60B
$2.54B
$2.62B
$2.53B
$2.52B
$2.56B
$2.60B
$2.61B
$2.60B
Inventory
$411.00M
$395.00M
$382.00M
$356.00M
$346.00M
$344.00M
$338.00M
$346.00M
$348.00M
$343.00M
$338.00M
$340.00M
Total current assets
$7.17B
$7.82B
$7.96B
$8.76B
$7.68B
$7.91B
$7.30B
$7.81B
$7.85B
$8.36B
$7.83B
$8.43B
Goodwill
$10.31B
$10.57B
$10.80B
$10.59B
$10.69B
$10.79B
$10.94B
$11.16B
$11.20B
$11.39B
$11.44B
$11.64B
Total assets
$28.31B
$28.91B
$29.27B
$29.37B
$28.94B
$29.24B
$28.70B
$29.42B
$29.68B
$31.20B
$30.68B
$31.59B
Total current liabilities
$4.76B
$5.42B
$5.49B
$5.54B
$4.31B
$4.45B
$4.27B
$4.56B
$4.46B
$6.15B
$5.57B
$5.32B
Short-term debt
$120.00M
$107.00M
$102.00M
$95.00M
$92.00M
$88.00M
$84.00M
$85.00M
$79.00M
$81.00M
$160.00M
$164.00M
Long-term debt
$14.88B
$12.77B
$12.77B
$12.78B
$13.08B
$13.08B
$13.09B
$13.10B
$13.09B
$13.13B
$13.09B
$13.08B
Total debt
$15.00B
$12.88B
$12.87B
$12.87B
$13.17B
$13.17B
$13.18B
$13.19B
$13.17B
$13.21B
$13.25B
$13.24B
Total liabilities
$22.80B
$21.24B
$21.40B
$21.30B
$20.39B
$20.58B
$20.40B
$20.72B
$20.70B
$22.35B
$21.98B
$22.00B
Shareholders' equity
$1.61B
$3.45B
$3.48B
$3.83B
$4.17B
$4.18B
$3.75B
$4.01B
$4.22B
$4.81B
$4.66B
$5.44B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$824.00M
$586.00M
$747.00M
$1.04B
-$331.00M
$815.00M
$936.00M
$1.06B
$731.00M
$1.64B
$585.00M
$1.28B
Capital expenditures
$208.00M
$240.00M
$145.00M
$216.00M
$330.00M
$173.00M
$193.00M
$280.00M
$364.00M
$180.00M
$168.00M
$198.00M
Free cash flow
$616.00M
$346.00M
$602.00M
$829.00M
-$661.00M
$642.00M
$743.00M
$778.00M
$367.00M
$1.46B
$417.00M
$1.08B
Investing cash flow
-$333.00M
$3.33B
-$194.00M
$667.00M
-$372.00M
-$187.00M
-$314.00M
-$385.00M
-$389.00M
-$317.00M
-$203.00M
-$298.00M
Financing cash flow
-$317.00M
-$2.66B
-$154.00M
-$498.00M
-$372.00M
-$648.00M
-$996.00M
-$323.00M
-$434.00M
-$1.24B
-$1.18B
-$479.00M
Share buybacks
$110.00M
$278.00M
$270.00M
$124.00M
$0
$348.00M
$747.00M
$93.00M
$198.00M
$318.00M
$1.04B
$255.00M
Stock-based compensation
$18.00M
$17.00M
$19.00M
$16.00M
$15.00M
$21.00M
$20.00M
$38.00M
$25.00M
$25.00M
$44.00M
$35.00M
Depreciation & amortization
$216.00M
$208.00M
$208.00M
$209.00M
$193.00M
$206.00M
$208.00M
$218.00M
$231.00M
$229.00M
$215.00M
$217.00M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.